Immunobiology of Proteins and Peptides V

Front Matter

Developments toward a Recombinant Pertussis Vaccine

• W. Neal Burnette, David W. Whiteley, Vernon L. Mar, Drusilla L. Burns, Harvey R. Kaslow, Witold Cieplak et al.

Prospects and Problems in Synthetic Vaccine Development: What did We Learn from the Cholera Toxin System?

• Chaim O. Jacob

New Concepts in Vaccines for Mucosal Non-Enteric Human Bacterial Pathogens

• M. A. J. Westerink, A. A. Campagnari, M. B. Nelson, T. F. Murphy, M. A. Apicella

Stable Recombinant Avirulent Salmonella Vaccine Strains

• Roy Curtiss III, Sandra M. Kelly, Paul A. Gulig, Koji Nakayama

Cytotoxic and Helper T-Lymphocyte Responses to Antibody Recognition Regions on Influenza Virus Hemagglutinin

• M. Zouhair Atassi, Jose V. Torres, Philip R. Wyde

Haemophilus b Oligosaccharide-CRM197 and Other Haemophilus b Conjugate Vaccines: A Status Report

• David H. Smith, Dace Viceps Madore, Ronald J. Eby, Porter W. Anderson, Richard A. Insel, Cynthia L. Johnson

The Application of Molecular Biology to the Development of Novel Vaccines

• P. J. Kniskern, A. Hagopian, P. Burke, N. Dunn, D. L. Montgomery, L. D. Schultz et al.

Studies on the Clonality of the Antibody Response to a Protein Epitope

• Eli Benjamini, Matthew L. Andria, Soshana Levy, Cherry Y. Leung

Anti-Idiotype Tumor Vaccines

• Malaya Bhattacharya-Chatterjee, Heinz Kohler

A VH Region Synthetic Peptide Induces Antibodies Which Bind Native Immunoglobulins and Augment an Immune Response to Antigen

• F. A. Bonilla, R. S. Anderson, M. Z. Atassi, C. A. Bona

Enhancement of Primary and Secondary Immune Responses by Interferon-Gamma

• Tilahun Yilma, Sally Owens, Elizabeth H. Fennie, Kevin P. Anderson

Interleukin 1 and Its Synthetic Peptides as Adjuvants for Poorly Immunogenic Vaccines

• G. Antoni, R. Presentini, F. Perin, L. Nencioni, L. Villa, S. Censini et al.

Protection Induced by Synthetic Peptides Corresponding to Three Serotypes in Foot and Mouth Disease Virus

• Charles Gale, Tim Doel, Gerry Brooke, Don White, Grace Mulcahy, Richard DiMarchi

Characterization of a Synthetic Envelope Peptide of SRV-1 and SRV-2 Virus That Specifically Binds Rhesus Anti-SRV-1 and Anti-SRV-2 Neutralizing Antibodies

• A. Malley, S. Shiigi, E. Benjamini, L. Werner, C. Y. Leung, H.-S. Kwang et al.

Synthetic Peptide Representing a T-Cell Epitope of CRM197 Substitutes as Carrier Molecule in a Haemophilus Influenzae Type B (HIB) Conjugate Vaccine

• Garvin S. Bixler Jr., Ronald Eby, Kathy M. Dermody, Robert M. Woods, Robert C. Seid, Subramonia Pillai

The Use of Mouse Class II MHC Peptides to Produce Site-Specific Monoclonal Antibodies

• Christopher J. Krco, Thomas G. Beito, Roger G. Little, Jay Zeller, Daniel M. McCormick, Chella S. David

Epitope Mimicry by Anti-Idiotype Sequences in Reverse Orientation

• Dennis W. Metzger, Clayton W. Naeve, Victor H. Van Cleave

Vaccine-Containing Biodegradable Microspheres Specifically Enter the Gut-Associated Lymphoid Tissue Following Oral Administration and Induce a Disseminated Mucosal Immune Response

• John H. Eldridge, Jonathan A. Meulbroek, Jay K. Staas, Thomas R. Tice, Richard M. Gilley

Potentiation of Cell-Mediated Immune Responses Directed against P. Falciparum Sporozoite Peptide Vaccine by Immunomodulators

• Donna M. Russo, John S. Sundy, Henry C. Maguire, William P. Weidanz